Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

3.52
Delayed Data
As of May 23
 0.00 / 0.00%
Today’s Change
1.65
Today|||52-Week Range
4.69
+40.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$75.8M

Company Description

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Contact Information

Imprimis Pharmaceuticals, Inc.
12264 El Camino Real
San Diego California 92130
P:(858) 704-4040
Investor Relations:

Employees

Shareholders

Individual stakeholders22.07%
Other institutional21.81%
Mutual fund holders2.98%

Top Executives

Mark L. BaumChief Executive Office & Director
Clayton D. EdwardsChief Operating Officer
Andrew R. BollCFO, Secretary & Principal Accounting Officer
John P. SaharekChief Commercial Officer
Gary W. SeelhorstVice President-Business Development